Internal Medicine · New York, NY
NPI
1083765531
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1302 Amsterdam Ave
New York, NY, 10027
Phone (212) 665-8012
Groups this clinician bills Medicare through
Medicare paid, 2024
$42K
709 services
Medicare patients, 2024
121
Average age 71
Drug cost, 2024
$5.0M
41,917 prescriptions
Company payments, 2025
$3,884
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael Correa was code 99214 (office e&m - established), 183 times for 108 patients. In total Michael Correa billed 709 services in 14 codes, and Medicare paid $42K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 183 | 108 | $100.61 | $18K |
| 36415 Venipuncture Blood Collection | Office | 137 | 88 | $8.65 | $1,185 |
| 99213 Office E&M - Established | Office | 112 | 69 | $74.90 | $8,388 |
| 93000 Electrocardiogram | Office | 83 | 73 | $10.83 | $899 |
| 99443 Telephone Services | Office | 64 | 48 | $106.56 | $6,820 |
| 99442 Telephone Services | Office | 51 | 40 | $75.21 | $3,836 |
| 94060 Pulmonary Function Testing | Office | 26 | 26 | $32.54 | $846 |
| G0008 Administration of influenza virus vaccine | Office | 18 | 18 | $34.30 | $617 |
| 94010 Pulmonary Function Testing | Office | 16 | 16 | $18.56 | $297 |
| 90656 Vaccine Product | Office | 12 | 12 | $21.90 | $263 |
By year: 2022 $64K for 1,021 services; 2023 $61K for 948 services; 2024 $42K for 709 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 137 | 88 | $8.65 | $1,185 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael Correa prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,261 prescriptions and refills. In total Michael Correa wrote 41,917 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,261 | 6,031 | 671 | $37K |
| Omeprazole Generic | 1,608 | 3,720 | 481 | $21K |
| Amlodipine Besylate Generic | 1,471 | 3,944 | 446 | $9,507 |
| Gabapentin Generic | 1,042 | 2,090 | 299 | $10K |
| Metformin Hcl Generic | 969 | 2,544 | 281 | $6,601 |
| Famotidine Generic | 941 | 2,099 | 301 | $10K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 887 | 1,298 | 192 | $38K |
| Fluticasone Propionate Generic | 829 | 1,110 | 219 | $6,403 |
| Levothyroxine Sodium Generic | 786 | 2,023 | 206 | $13K |
| Metoprolol Succinate Generic | 771 | 1,940 | 210 | $14K |
| Diclofenac Sodium Generic | 757 | 827 | 258 | $35K |
| Rosuvastatin Calcium Generic | 679 | 1,785 | 199 | $9,465 |
| Losartan Potassium Generic | 677 | 1,820 | 200 | $8,104 |
| Glipizide Er Glipizide | 672 | 1,796 | 187 | $14K |
| Pantoprazole Sodium Generic | 598 | 1,322 | 170 | $5,855 |
Brand drugs: 6,473 claims; generic drugs: 34,245 claims; opioid claims: 346.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael Correa $3,884 ($3,884 in general payments such as food, travel and fees) from 30 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $547.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 17 | $547 |
| Abbvie Inc. ABBV | 24 | $389 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $281 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 11 | $277 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $265 |
| Exact Sciences Corporation EXAS | 10 | $208 |
| Novo Nordisk Inc NVO | 7 | $184 |
| Pfizer Inc. PFE | 10 | $171 |
| GlaxoSmithKline, LLC. GSK | 11 | $170 |
| Lilly USA, LLC LLY | 6 | $154 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.